#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypomagnesaemia Neurofibroma Mitochondrial DNA depletion Oropharyngeal cancer recurrent Neoplasm malignant Cryoglobulinaemia Fabry's disease Epstein-Barr virus associated lymphoproliferative disorder Hereditary neuropathic amyloidosis Endocrine ophthalmopathy Subarachnoid haemorrhage Turner's syndrome Giant cell tumour of tendon sheath Acute leukaemia Familial dilated cardiomyopathy More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Leiomyosarcoma metastatic Osteosarcoma recurrent – Trials in Disease Inclusion body myositis Choroid melanoma – Diagnostics CADASIL Fragile X syndrome – Trials in Disease Krabbe’s disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Somatostatin Gallium (68Ga) Gozetotide Romidepsin Folic Acid Tazemetostat Dicloxacillin Pegcetacoplan Labetalol Hydrochloride Regn7257 Sar441566 Sodium Iodide Melphalan Hydrochloride SODIUM SULFIDE NONAHYDRATE L-Arginine Hydrochloride GSK3862995B Hydroxypropyl Cellulose Lf Sertraline Hydrochloride Lymecycline TIL CELLS Octreotide Acetate More therapies…

    Learn about Your Condition

    Mitral valve prolapse Wiskott-Aldrich syndrome Aortic stenosis Sickle cell anaemia Cognitive disorder Cold type haemolytic anaemia Colonoscopy Juvenile idiopathic arthritis Aneurysm ruptured Chondrocalcinosis Ear discomfort Arthralgia Dementia with Lewy bodies Cutaneous calcification Polymyositis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinikum Nuernberg

Klinikum Nuernberg

Breslauer Strasse 201, Langwasser, Nürnberg, 90471, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study comparing chemotherapy with or without radiation therapy in patients with resectable gastroesophageal junction cancer using docetaxel, oxaliplatin, fluorouracil and calcium folinate

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Docetaxel
    • Fluorouracil
    Germany

  • Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Carboplatin
    • Infliximab
    • Mycophenolate Mofetil
    Austria Belgium Czechia France Germany Hungary +5

  • Study on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds

    Not recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
    Germany

  • Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    • Pembrolizumab
    Austria Belgium Czechia France Germany Hungary +6

  • Study on Nivolumab and Ipilimumab for Patients with Untreated Unresectable or Metastatic Urothelial Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Gemcitabine
    Czechia Denmark France Germany Greece Italy +5

  • Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Belzutifan
    • Lenvatinib
    • Cabozantinib
    Austria Belgium Czechia Finland France Germany +7

  • Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cetrelimab
    • Gemcitabine Hydrochloride
    Belgium Czechia France Germany Italy The Netherlands +3

  • Study of Pembrolizumab, Vibostolimab, and Belzutifan for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Abiraterone
    • Olaparib
    • Vibostolimab
    Austria Denmark Finland France Germany Ireland +5

  • Study on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Rectal cancer stage II
    Investigated Drugs:
    • Capecitabine
    Austria Germany

  • Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bi 1015550
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    Austria Belgium Croatia Czechia Denmark Estonia +14
Previous Page
1 … 6 7 8 9 10 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!